Search research articles
Contact Us
Filters
Showing results (31-40 of 117) with videos related to
Page
of 12
Sort By:
Cancer
|
December 2, 2022
Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy
Tejaswini M Dhawale, P Connor Johnson, Mahmoud R Gaballa, et al.
British Journal of Haematology
|
October 20, 2025
Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy
Osnat Itzhaki Ben Zadok, Panagiotis Simitsis, Caron Jacobson, et al.
Transplantation and Cellular Therapy
|
December 13, 2024
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data
Moataz Ellithi, Magdi Elsallab, Matthew A Lunning, et al.
Cytometry. Part B, Clinical Cytometry
|
April 29, 2021
Detection of CAR-T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories
Ulrika Johansson, Kathleen Gallagher, Victoria Burgoyne, et al.
Acta Medica Academica
|
June 2, 2021
Patient with Lobular Carcinoma of the Breast and Activating AKT1 E17K Variant
Harsha Trivedi, Omar Hamdani, Brittani Thomas, et al.
Blood
|
July 3, 2014
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
Sonia Guedan, Xi Chen, Aviv Madar, et al.
Transplantation and Cellular Therapy
|
August 13, 2025
Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing reduced-intensity allogeneic hematopoietic cell transplantation
Christof C Smith, Jooho Chung, Areej El-Jawahri, et al.
The Oncologist
|
July 17, 2021
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients
Annabelle J Anandappa, Gabriela S Hobbs, Bimalangshu R Dey, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2021
Healthcare Utilization and End-of-Life Outcomes in Patients Receiving CAR T-Cell Therapy
P Connor Johnson, Caron Jacobson, Alisha Yi, et al.
Cancer
|
September 11, 2019
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma
Jeremy S Abramson, Kelly E Irwin, Matthew J Frigault, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 117) with videos related to
Sort By:
Page
of 12
Cancer
|
December 2, 2022
Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy
Tejaswini M Dhawale, P Connor Johnson, Mahmoud R Gaballa, et al.
British Journal of Haematology
|
October 20, 2025
Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy
Osnat Itzhaki Ben Zadok, Panagiotis Simitsis, Caron Jacobson, et al.
Transplantation and Cellular Therapy
|
December 13, 2024
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data
Moataz Ellithi, Magdi Elsallab, Matthew A Lunning, et al.
Cytometry. Part B, Clinical Cytometry
|
April 29, 2021
Detection of CAR-T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories
Ulrika Johansson, Kathleen Gallagher, Victoria Burgoyne, et al.
Acta Medica Academica
|
June 2, 2021
Patient with Lobular Carcinoma of the Breast and Activating AKT1 E17K Variant
Harsha Trivedi, Omar Hamdani, Brittani Thomas, et al.
Blood
|
July 3, 2014
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
Sonia Guedan, Xi Chen, Aviv Madar, et al.
Transplantation and Cellular Therapy
|
August 13, 2025
Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing reduced-intensity allogeneic hematopoietic cell transplantation
Christof C Smith, Jooho Chung, Areej El-Jawahri, et al.
The Oncologist
|
July 17, 2021
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients
Annabelle J Anandappa, Gabriela S Hobbs, Bimalangshu R Dey, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2021
Healthcare Utilization and End-of-Life Outcomes in Patients Receiving CAR T-Cell Therapy
P Connor Johnson, Caron Jacobson, Alisha Yi, et al.
Cancer
|
September 11, 2019
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma
Jeremy S Abramson, Kelly E Irwin, Matthew J Frigault, et al.
Page
of 12